Author

Serena Diazzi

InsermORCID 0000-0001-5328-1342Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell signaling & trafficking· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

Frédéric Larbret· 2 shared Marcel DeckertiD· 2 shared Pierric Biber· 2 shared Sophie Tartare‐DeckertiD· 2 shared Alexandrine CarminatiiD· 1 shared Catherine JamardiD· 1 shared Christophe A. J. GirardiD· 1 shared Christopher RoveraiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Frédéric Larbret

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyOncogenesisPeer-reviewedJun 13, 2026

Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway

Margaux Lecacheur, Ilona Berestjuk, Alexandrine Carminati…·Sophie Tartare‐Deckert

This study shows that ECM stiffness influences dedifferentiated melanoma cells via DDR1/2 and YAP, affecting their behavior and drug resistance.

3 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 2, 2026

PSMD14 drives melanoma cell survival and MAPK inhibitor resistance through histone H2A deubiquitination

Michael Ohanna, Pierric Biber, Mira Kahil…·Marcel Deckert

This study identifies PSMD14 as a key driver of melanoma survival and resistance to MAPK inhibitors by deubiquitinating histone H2A, altering chromatin state and gene expression.

DOI 10.64898/2026.02.27.708453

𝕏 PostBluesky

Cancer BiologyCell Death and DiseasePeer-reviewedOct 6, 2025

Atypical contribution of caspase-3 to melanoma cancer cell motility by regulation of coronin 1B activity

Kévin Berthenet, Serena Diazzi, Catherine Jamard…·Gabriel Ichim

This study identifies a non-apoptotic role for caspase-3 in melanoma cell motility by regulating coronin 1B activity, suggesting it as a potential target for anti-metastatic therapies.

2 citations

humanexperimental assay

𝕏 PostBluesky